Dashboard
Manage Tickers

LEGNLegend Biotech Corp

Nasdaq legendbiotech.com


$ 44.68 $ -0.23 (-0.51 %)    

Thursday, 27-Jun-2024 15:59:50 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 482.07 $ 1.24 (0.26 %)
DIA $ 391.62 $ 0.32 (0.08 %)
SPY $ 546.37 $ 0.86 (0.16 %)
TLT $ 93.57 $ 0.37 (0.4 %)
GLD $ 215.08 $ 2.41 (1.13 %)
$ 44.66
$ 44.13
$ 0.00 x 0
$ 0.00 x 0
$ 43.81 - $ 44.98
$ 38.60 - $ 77.32
652,600
na
16.25B
$ 0.58
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

assessing-legend-biotech-insights-from-15-financial-analysts
Assessing Legend Biotech: Insights From 15...
06/21/2024 15:00:56

rbc-capital-reiterates-outperform-on-legend-biotech-maintains-86-price-target
RBC Capital Reiterates Outperform on Legen...
06/21/2024 14:24:27

RBC Capital analyst Leonid Timashev reiterates Legend Biotech (NASDAQ:LEGN) with a Outperform and maintains $86 price target.

piper-sandler-reiterates-overweight-on-legend-biotech-maintains-90-price-target
Piper Sandler Reiterates Overweight on Leg...
06/17/2024 17:11:53

Piper Sandler analyst Edward Tenthoff reiterates Legend Biotech (NASDAQ:LEGN) with a Overweight and maintains $90 price target.

legend-biotechs-cancer-drug-the-most-attractive-product-set-for-growth-analyst
Legend Biotech's Cancer Drug, 'The Most At...
06/17/2024 16:15:05

Legend Biotech analyst predicts growth for Carvykti. The Multiple Myeloma drug could become a $5B+ product.

truist-securities-initiates-coverage-on-legend-biotech-with-buy-rating-announces-price-target-of-88
Truist Securities Initiates Coverage On Le...
06/17/2024 10:42:11

Truist Securities analyst Asthika Goonewardene initiates coverage on Legend Biotech (NASDAQ:LEGN) with a Buy rating and anno...

novavax-and-agios-pharmaceuticals-were-among-the-10-biggest-mid-cap-gainers-last-week-june-1-june-7-are-these-in-your-portfolio
Novavax And Agios Pharmaceuticals Were Amo...
06/09/2024 18:29:27

Mid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX, causing analysts to raise their ...

hc-wainwright--co-reiterates-buy-on-legend-biotech-maintains-73-price-target
HC Wainwright & Co. Reiterates Buy on Lege...
06/06/2024 10:54:20

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Legend Biotech (NASDAQ:LEGN) with a Buy and maintains $73 price t...

unveiling-18-analyst-insights-on-legend-biotech
Unveiling 18 Analyst Insights On Legend Bi...
06/04/2024 12:00:38

hc-wainwright--co-reiterates-buy-on-legend-biotech-maintains-73-price-target
HC Wainwright & Co. Reiterates Buy on Lege...
06/04/2024 10:26:19

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Legend Biotech (NASDAQ:LEGN) with a Buy and maintains $73 price t...

Core News & Articles
Johnson & Johnson Announces Results From A...
06/03/2024 19:58:54

73 percent reduction in risk of disease progression or death seen with CARVYKTI® in the CARTITUDE-4 study in a subset of patien...

hc-wainwright--co-maintains-buy-on-legend-biotech-lowers-price-target-to-73
HC Wainwright & Co. Maintains Buy on Legen...
05/24/2024 10:13:51

HC Wainwright & Co. analyst Mitchell Kapoor maintains Legend Biotech (NASDAQ:LEGN) with a Buy and lowers the price targe...

deutsche-bank-initiates-coverage-on-legend-biotech-with-buy-rating-announces-price-target-of-60
Deutsche Bank Initiates Coverage On Legend...
05/23/2024 17:01:13

Deutsche Bank analyst James Shin initiates coverage on Legend Biotech (NASDAQ:LEGN) with a Buy rating and announces Price Ta...

Core News & Articles
MaxCyte Signs License Agreement With Legen...
05/22/2024 12:08:34

rbc-capital-maintains-outperform-on-legend-biotech-raises-price-target-to-86
RBC Capital Maintains Outperform on Legend...
05/14/2024 15:31:54

RBC Capital analyst Leonid Timashev maintains Legend Biotech (NASDAQ:LEGN) with a Outperform and raises the price target fro...

legend-biotech-stock-a-deep-dive-into-analyst-perspectives-14-ratings
Legend Biotech Stock: A Deep Dive Into Ana...
05/14/2024 12:00:19

hc-wainwright--co-maintains-buy-on-legend-biotech-lowers-price-target-to-86
HC Wainwright & Co. Maintains Buy on Legen...
05/14/2024 10:56:55

HC Wainwright & Co. analyst Mitchell Kapoor maintains Legend Biotech (NASDAQ:LEGN) with a Buy and lowers the price targe...

legend-biotech-expects-cash-and-equivalents-of-13b-as-of-march-end-to-provide-financial-runway-into-2026-when-it-anticipates-achieving-an-operating-profit
Legend Biotech Expects Cash And Equivalent...
05/13/2024 11:04:50

legend-biotech-q1-2024-gaap-eps-016-beats-034-estimate-sales-93991m-miss-152631m-estimate
Legend Biotech Q1 2024 GAAP EPS $(0.16) Be...
05/13/2024 11:02:15

Legend Biotech (NASDAQ:LEGN) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.34...

hc-wainwright--co-reiterates-buy-on-legend-biotech-maintains-87-price-target
HC Wainwright & Co. Reiterates Buy on Lege...
05/09/2024 18:56:45

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Legend Biotech (NASDAQ:LEGN) with a Buy and maintains $87 price t...

hc-wainwright--co-reiterates-buy-on-legend-biotech-maintains-87-price-target
HC Wainwright & Co. Reiterates Buy on Lege...
04/23/2024 10:19:23

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Legend Biotech (NASDAQ:LEGN) with a Buy and maintains $87 price t...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)